by bruyere | Dec 19, 2020 | Deprescribing Research
Dr. Barbara Farrell and the Bruyère Deprescribing Research Team received the 2019 Betty Havens Prize for Knowledge Translation Aging for outstanding achievements related to the spread and uptake of their deprescribing guidelines. Since 2013, the team has worked... by bruyere | Dec 12, 2020 | Deprescribing Research
In Canada, older adults living in long-term care (LTC) homes experience polypharmacy at higher rates than their community-living counterparts and strategies to reduce polypharmacy are urgently needed. This research project began as an environmental scan with Ontario... by bruyere | Mar 4, 2019 | Deprescribing Research
The four evidence-based deprescribing guidelines and algorithms produced through the leadership of the Bruyère Research Institute and the Ontario Pharmacy Evidence Network, and the guideline developed through an NHMRC-ARC Dementia Research Fellowship have been built... by bruyere | Jan 7, 2019 | Deprescribing Research
Using the evidence-based deprescribing guideline method established through the Bruyère Research Institute and the Ontario Pharmacy Evidence Network, Dr. Reeve developed an Australian/Canadian focused prescribing guideline for acetylcholinesterase inhibitors and... by bruyere | Jan 7, 2019 | Deprescribing Research
This knowledge mobilization grant supported a variety of strategies designed to help health care providers and members of the public use deprescribing guidelines effectively. These included whiteboard training videos, mobile apps, webinars, a wide-reaching social... by bruyere | Jun 18, 2018 | Deprescribing Research
Prescribing cascades occur when a drug is used to treat the side effect of another drug. How and why prescribing cascades start and continue, their impact on people, and how they can be prevented or reversed are all unknown. This research project is helping to...
